102 reports of this reaction
4.9% of all TAZAROTENE reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for TAZAROTENE, manufactured by Almirall, LLC. There are 102 FDA adverse event reports linking TAZAROTENE to DRUG INEFFECTIVE. This represents approximately 4.9% of all 2,077 adverse event reports for this drug.
Patients taking TAZAROTENE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among TAZAROTENE users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for TAZAROTENE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 102 FDA reports for TAZAROTENE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 4.9% of all adverse event reports for TAZAROTENE, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking TAZAROTENE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.